Clinical Trials
Our participation in clinical trials
At NJRetina, our physicians are actively involved in research as part of a host of multicentered clinical trials on new therapeutic approaches to retinal diseases. We have participated in a numerous national eye research studies, including:
Open Clinical Trials
Studies that are currently recruiting patients| Date Published | Study | Condition | Location | Accepting Patients? |
|---|---|---|---|---|
| August 15, 2017 | Aerpio AKB-97780-Cl-5001 | Non-Proliferative Diabetic Retinopathy | Central NJ | Yes |
| July 12, 2017 | Anti-VEGF Treatment for Prevention of PDR/DME | Diabetic Retinopathy; Diabetic Macular Edema | Northern NJ | Yes |
| June 16, 2017 | Clearside "Tybee" CLS1004-201 | Diabetic Macular Edema | Northern NJ | Yes |
| June 16, 2017 | Clearside "Sapphire" CLS1003-301 | Retinal Vein Occlusion | Northern NJ | Yes |
| June 16, 2017 | TOGA (Univ. of Virginia) | Geographic Atrophy | Central NJ | Yes |
Not currently enrolling
Studies that have been completed or are currently not accepting patients| Date Published | Study | Condition | Location | Accepting Patients? |
|---|---|---|---|---|
| August 15, 2017 | ALA Study | Age-Related Macular Degeneration | Northern NJ | No |
| July 12, 2017 | Catt | Age-Related Macular Degeneration | Northern NJ | No |
| July 12, 2017 | Lpath Nexus LT1009-oPH-003 | Exudative Age-Related Macular Degeneration | Northern NJ | No |
| July 12, 2017 | VGFT-OD-1009 | Diabetic Macular Edema | Northern NJ | No |
| July 12, 2017 | VGFT-OD-0706 | Diabetic Macular Edema | Northern NJ | No |
| July 12, 2017 | VEGF Trap-Eye in AMD: Phase 2 | Macular Degeneration | Northern NJ | No |
| July 12, 2017 | VEGF Trap-Eye in AMD: Phase 3 | Macular Degeneration | Northern NJ | No |
| July 12, 2017 | Vascular Endothelial Growth Factor Trap | Macular Degeneration | Northern NJ | No |
| July 12, 2017 | Harbor | Age-Related Macular Degeneration | Northern NJ | No |
| July 12, 2017 | TG-MV-005 | Exudative Age-Related Macular Degeneration; Focal Vitreomacular Adhesion | Northern NJ | No |
| July 12, 2017 | Quark QRK202 | Diabetic Macular Edema; Diabetic Retinopath; Choroidal Neovascularization | Northern NJ | No |
| July 12, 2017 | Alcon C-12-006 | Neovascular Age-Related Macular Degeneration | Northern NJ | No |
| July 12, 2017 | OHR-002 | Neovasclar Age-Related Macular Degeneration | Northern NJ | No |
| June 12, 2017 | Double-Masked Uveitis Treatment | Uveitis; Posterioir, Disorder | Northern NJ | No |
| June 12, 2017 | Retinal Vein Occlusion | Macular Edema; Central Retinal Vein Occlusion | Northern NJ | No |
| June 12, 2017 | Non-exudative “Dry” Age-Related Macular Degeneration (AMD) Studies | Age-Related Maculopathy | Northern NJ | No |
| June 12, 2017 | TG-MV-014 | Vitreomacular Adhesion | Northern NJ | No |
| June 16, 2017 | Allergan "Cedar" 150998-005 | Macular Degeneration | Northern NJ | No |
| June 16, 2017 | Score 2 CRVO (Penn State) | Central Retinal Vein Occlusion | Central NJ | No |
| June 16, 2017 | Santen 32-009 | Non-Infectious Uveitis | Central NJ | No |
| June 16, 2017 | Regeneron RUBY | Diabetic Macular Edema | Central NJ | No |
| June 16, 2017 | Genentech Omaspect GX30191 EXT | Geographic Atrophy | Central NJ | No |
| June 16, 2017 | Roche "Avenue" BP29647 | Choroidal Neovascularization | Northern NJ | No |
| June 16, 2017 | Alcon "Hawk" AMD RTH-258-C001 | Neovascular Age-Related Macular Degeneration | Central NJ | No |
| June 16, 2017 | Alimera "Paladin" M-01-15-004 | Diabetic Macular Edema | Central NJ | No |
| June 16, 2017 | Regeneron ONYX | Neovascular Age-Related Macular Degeneration | Central NJ | No |
| June 16, 2017 | OHR 1601 | Age-Related Macular Degeneration | Central NJ | No |
For patients interested in enrolling in a clinical trial, please contact one of our offices.
To learn more about these clinical trials, visit www.clinicaltrials.gov
